Viatris News

Dividend Yield and Growth Stock List by Goldman

Seeking AlphaApr 22 11:04 ET

Zacks Industry Outlook Highlights Teva, Dr. Reddy's and Viatris

Yahoo FinanceApr 19 06:00 ET

3 Generic Drug Stocks to Watch Amid Challenging Market Prospects

Yahoo FinanceApr 18 11:12 ET

Bill Miller's Latest 13 Stock Picks

Yahoo FinanceApr 18 09:54 ET

Viatris' Proposed Femoston, Duphaston UK Rights Divestment Being Considered, CMA Says

Viatris (VTRS) and Theramex's undertakings related to Viatris' proposed divestment of the UK rights to its Femoston and Duphaston products to Theramex are being considered by Britain's Competition and

MT NewswiresApr 18 09:16 ET

CMA: Merger Probe Was Announced on April 4

CMA: Merger Probe Was Announced on April 4

Dow JonesApr 18 07:04 ET

CMA: Mulls That There Are Reasonable Grounds for Believing That Undertakings Might Be Accepted

CMA: Mulls That There Are Reasonable Grounds for Believing That Undertakings Might Be Accepted

Dow JonesApr 18 07:02 ET

Express News | Uk's Cma Says Now Has Until 17 June 2024 to Decide Whether to Accept Undertakings in Theramex/ Viatris Deal

Moomoo 24/7Apr 18 07:00 ET

Express News | Uk's Cma: Cma to Consider Undertakings Offered on Theramex/ Viatris Deal

Moomoo 24/7Apr 18 07:00 ET

CVS Favors Humira Copycats Hurting AbbVie's Market Share: Evercore

Seeking AlphaApr 17 09:26 ET

Viatris to Report First Quarter 2024 Financial Results on May 9, 2024

Viatris Inc. (NASDAQ: VTRS) will report its first quarter 2024 financial results on Thursday, May 9, 2024, before the open of the U.S. financial...

PR NewswireApr 16 16:30 ET

Viatris Launches New Generic Treatment Option for Multiple Sclerosis in Canada

Viatris (VTRS) said Monday its Glatiramer Acetate injection 20 mg/mL for the treatment of relapsing-remitting multiple sclerosis is now available in Canada. The once-daily injection is the first gener

MT NewswiresApr 15 10:26 ET

Express News | Viatris Appoints Corinne Le Goff as Chief Commercial Officer

Moomoo 24/7Apr 15 08:00 ET

Express News | Viatris Reports Launch Of First Bioequivalent Generic Version Of Copaxone 20 Mg/mL Once-Daily In Canada

Moomoo 24/7Apr 15 07:01 ET

Express News | Viatris Announces Launch of First Bioequivalent Generic Version of Copaxone® 20 Mg/Ml Once-Daily in Canada

Moomoo 24/7Apr 15 06:59 ET

New Additions to Goldman's High Operating Leverage List

Seeking AlphaApr 10 11:58 ET

Express News | Theramex Says Currently Considering CMA's Decision, In Particular Whether And How Best To Address Competition Concerns Regarding Deal With Viatris; " Co Remains Committed To Offering Women Choice To Make Empowered Decisions About HRT At Competitive Prices

Moomoo 24/7Apr 5 12:53 ET

Viatris- Theramex Deal for Women's Care Products Raises Antitrust Concerns in U.K.

Seeking AlphaApr 4 08:55 ET

Competition Watchdog Says HRT Drug Deal Could Raise Prices

Yahoo FinanceApr 4 07:50 ET

UPDATE 1-UK Watchdog Says Theramex-Viatris Deal Raises Competition Concerns

Yahoo FinanceApr 4 06:52 ET